141 related articles for article (PubMed ID: 8129188)
1. Apolipoproteins C-II and C-III in peripheral arterial disease.
Alessandri C; Basili S; Maurelli M; Andreozzi P; Colletta A; Paradiso M; Cordova C
Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
3. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
Breckenridge WC; Alaupovic P; Cox DW; Little JA
Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
[TBL] [Abstract][Full Text] [Related]
5. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
7. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Patsch W; Sorlie PD; Heiss G; Bond MG; Davis CE
Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665
[TBL] [Abstract][Full Text] [Related]
8. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
Lecomte E; Herbeth B; Paille F; Steinmetz J; Artur Y; Siest G
Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
11. Influence of apolipoproteins on the anatomical distribution of arterial disease.
Wiseman SA; Powell JT; Barber N; Humphries SE; Greenhalgh RM
Atherosclerosis; 1991 Aug; 89(2-3):231-7. PubMed ID: 1686549
[TBL] [Abstract][Full Text] [Related]
12. [Serum apolipoproteins in uremic patients].
Fan JM; Xu GZ
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):451-3. PubMed ID: 8275822
[TBL] [Abstract][Full Text] [Related]
13. [Serum lipids and apolipoproteins AI, B100, CI and CII in patients with apoplexy].
Liu BW; Zhang ZH; Wu ZF; Fu MD; Zhang RJ; Fan P; Zhang P; Hu CH; Luo ZM; She LM
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Mar; 20(1):9-12. PubMed ID: 2507441
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
15. Alterations in levels of apolipoprotein C-III and C-II/C-III ratios in patients with liver disease.
Koga S; Yamamoto K; Ibayashi H
Gastroenterol Jpn; 1984 Feb; 19(1):65-71. PubMed ID: 6724249
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
Ito Y
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
[TBL] [Abstract][Full Text] [Related]
17. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
18. Apo B/Apo A-I ratio in central and peripheral arterial diseases.
Lima LM; Carvalho Md; Sabino Ade P; Mota AP; Fernandes AP; Sousa MO
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1160-5. PubMed ID: 18157393
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
20. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
